Company intelligence / Profile preview

HydroPeptide

Issaquah, Washington, United Stateshydropeptide.co.uk ↗

Ownership: Private
Employees: ~60
Development stage: Commercial

Overview

HydroPeptide’s products are clinically tested and designed to deliver visible improvements in skin health and appearance. Their peptide-based formulations have been shown to reduce signs of aging such as wrinkles and loss of elasticity while also addressing concerns like hyperpigmentation, sensitivity, and acne. The company emphasizes both clinical-grade results and luxury skincare experiences[1][2][10].

Therapeutic areas: Dermatology
Modalities: PeptidesSmall molecule (e.g., vitamin C, caffeine, botanical extracts)Biologic (peptides as biologically active molecules)
Industry: Non-Drug Biotech

Partnerships

BLC Cosmetics (exclusive distributor for Australia/New Zealand/Pacific Islands)The HydraFacial Company

Beyond the preview

Go deeper on HydroPeptide.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HydroPeptide.

Explore the full profile